Jennifer Pate, NP
Nurse Practitioner · Jackson, MSNPI 1972048304
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,853 of the $5,671 with a category attached, or 85.6%. It is spread thinly across 31 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,550 and has fallen 73.0% since, to $418 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $21.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Intuitive Surgical$886
- Atricure, Inc.$417
- Jazz Pharmaceuticals Inc.$370
- Boehringer Ingelheim$350
- Mallinckrodt Hospital Products Inc.$325
- plus $2K from 25 others
What the payments were for
- Travel & lodging$81814%
- Food & beverage$4,85386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 79 | $1,142 |
| Intuitive Surgical | 7 | $886 |
| Atricure, Inc. | 15 | $417 |
| Jazz Pharmaceuticals Inc. | 19 | $370 |
| Boehringer Ingelheim | 22 | $350 |
| Mallinckrodt Hospital Products Inc. | 14 | $325 |
| AstraZeneca | 12 | $308 |
| Sanofi | 14 | $282 |
| Regeneron Healthcare Solutions, Inc. | 13 | $266 |
| Actelion Pharmaceuticals US, Inc. | 10 | $253 |
| AbbVie | 12 | $233 |
| Pfizer | 7 | $140 |
| United Therapeutics Corporation | 6 | $112 |
| Pulmonx Corporation | 4 | $72 |
| Baxter Healthcare | 4 | $64 |
| ANI Pharmaceuticals, Inc. | 3 | $54 |
| Merck | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Mylan Specialty L.p. | 2 | $43 |
| Davol Inc. | 1 | $37 |
| BD | 1 | $29 |
| Inari Medical, Inc. | 1 | $25 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Harmony Biosciences LLC | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $18 |
| Novocure Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$780
- BREZTRI$138
- FARXIGA$138
- FASENRA$138
How this compares
$5,671 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $41,558 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $6,752 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $521 |
| Azithromycin | 14 | $180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $1,142 | $48,31050 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Jackson
- Jo Anna WarrenJackson$73K
- Michelle TharpJackson$28K
- Jennifer HollyJackson$16K
- Brandon ChambersJackson$12K
- Ramona BallJackson$9K
- Bonney SimmonsJackson$9K
- Catherine WellsJackson$9K
- Tamecia HerbertJackson$8K
- Amy HeidelbergJackson$7K
- Amy LemlyJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.